You Can Now Bet on Whether a Player Will Even Play. Regulators and the NFL Are Not Happy.

Kalshi and Polymarket have launched 'player participation' markets — trade whether an athlete suits up. The CFTC has warned about manipulation, and the NFL calls injury contracts 'inherently objectionable.'

August 27, 2026 at 12:11 PM EDT

2 min read

Prediction markets have found a new frontier, and it's a nervy one: contracts on whether a specific athlete will play in a given game. Buy or sell the likelihood a player is active; it resolves off the official game record. Kalshi and Polymarket both offer versions of it.

This is where the prediction-market boom runs straight into the thing sports leagues fear most.

Why 'will he play?' is different

A point spread is about performance. A participation market is about information — specifically, information a small number of people (team staff, the player, an agent, a trainer) have before anyone else. That's the textbook setup for an integrity problem, and regulators noticed. In March, the CFTC's Division of Market Oversight issued an advisory warning that contracts which "resolve or settle based on injuries to individual sports participants" may "create a heightened potential for manipulation or price distortion."

The leagues went further. The NFL, in a letter to the CFTC, called injury-based contracts "inherently objectionable." The concern is obvious: you don't want a market where someone with non-public medical information can quietly cash in — or worse, where the market creates an incentive to shade that information.

The loophole and the standoff

The platforms have leaned on careful contract language to keep the products inside regulatory lines, and notably, Kalshi moved to preemptively block athletes and politicians from trading on markets tied to their own outcomes (Axios reported the insider-trading ban in March). But the wording is unlikely to fully ease the integrity concerns that pushed leagues and regulators against injury-based betting in the first place. As of now, despite the advisory, the CFTC hasn't acted to pause the contracts — they remain live.

Why it matters

This is the sharpest test yet of how far the event-contract model can stretch. If participation markets survive, prediction platforms will have established that they can list almost any sports outcome — including ones traditional sportsbooks won't touch for integrity reasons. If regulators or the courts draw a line here, it tells you where the ceiling is. Either way, "will he play?" is now a market, and that sentence would have sounded absurd two years ago.

Watch

Inside Prediction Markets: What the Pros Know (and You Don’t) (Unabated)